-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $13

Benzinga·07/14/2026 11:27:53
Listen to the news
Barclays analyst Peter Warendorf maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $9 to $13.